Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden
- PMID: 36103477
- PMCID: PMC9473420
- DOI: 10.1371/journal.pone.0273567
Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden
Abstract
Background: Hypertrophic cardiomyopathy (HCM) is a major cause of sudden cardiac death (SCD) in the young. We aimed to characterize detailed family history, symptoms, hospital utilization and ECG changes before SCD.
Methods: We extracted all cases suffering SCD with HCM from the SUDDY cohort, which includes all cases of SCD between 2000-2010 in Sweden among individuals aged 0-35 years along with their controls. We gathered data from mandatory national registries, autopsy reports, medical records, ECGs (including military conscripts), and detailed family history from an interview-based questionnaire (with relatives, post-mortem).
Results: Thirty-eight cases (7 female), mean age 22 years, with HCM were identified. Among these, 71% presented with possible cardiac symptoms (chest pain [26%], syncope [22%], palpitations [37%]), before death; 69% received medical care (vs 21% in controls) within 180 days before death. The majority (68%) died during recreational activity (n = 14) or exercise/competitive sports (n = 12). Fifteen (39%) had a known cardiac disorder prior to death, with HCM being diagnosed pre-mortem in nine cases. 58% presented with abnormal ECG recordings pre-mortem, and 50% had a positive family history (1st-3rd generation) for heart disease.
Conclusion: In this comprehensive, nationwide study of SCD due to HCM, 87% (33/38) of cases had one or more abnormality prior to death, including cardiac symptoms, a positive family history, known cardiac disease or ECG abnormalities. They sought medical care prior death, to a larger extent than controls. These findings suggest that cardiac screening should be expanded beyond competitive athletes to aid SCD prevention in the young population with HCM.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark.Europace. 2016 Dec;18(12):1801-1808. doi: 10.1093/europace/euv403. Epub 2016 Jan 27. Europace. 2016. PMID: 26823388
-
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.Circulation. 2019 Nov 19;140(21):1706-1716. doi: 10.1161/CIRCULATIONAHA.119.040271. Epub 2019 Oct 21. Circulation. 2019. PMID: 31630535
-
Exercise related sudden cardiac death (SCD) in the young - Pre-mortal characterization of a Swedish nationwide cohort, showing a decline in SCD among athletes.Resuscitation. 2019 Nov;144:99-105. doi: 10.1016/j.resuscitation.2019.09.022. Epub 2019 Sep 24. Resuscitation. 2019. PMID: 31560990
-
Update: Causes and symptoms of sudden cardiac death in young athletes.Phys Sportsmed. 2015 Feb;43(1):44-53. doi: 10.1080/00913847.2015.1001306. Epub 2015 Feb 6. Phys Sportsmed. 2015. PMID: 25656358 Review.
-
Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.Clin Cardiol. 1995 Apr;18(4):189-98. doi: 10.1002/clc.4960180403. Clin Cardiol. 1995. PMID: 7788945 Review.
Cited by
-
Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy.Nat Cardiovasc Res. 2025 Jul;4(7):891-903. doi: 10.1038/s44161-025-00679-1. Epub 2025 Jul 2. Nat Cardiovasc Res. 2025. PMID: 40603582 Free PMC article.
-
An overview of the electrocardiographic monitoring devices in sports cardiology: Between present and future.Clin Cardiol. 2023 Sep;46(9):1028-1037. doi: 10.1002/clc.24073. Epub 2023 Jun 22. Clin Cardiol. 2023. PMID: 37349944 Free PMC article. Review.
-
Recommendations for cardiac screening and emergency action planning in youth football: a FIFA consensus statement.Br J Sports Med. 2025 May 27;59(11):751-760. doi: 10.1136/bjsports-2025-109751. Br J Sports Med. 2025. PMID: 40180446 Free PMC article.
References
-
- Maron BJ, Maron MS. Hypertrophic cardiomyopathy. The Lancet. 2013;381(9862):242–55. - PubMed
-
- Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al.. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733–79. doi: 10.1093/eurheartj/ehu284 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources